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SUMMARY
Severe forms of GDM have been conclusively associated
with significantly increased risk of developing DM later on
in life.  The long-term significance of GIGT has not yet
been definitely elucidated. The study was set up to
compare the present carbohydrate metabolism status and
anthropomorphic characteristics of women of women
diagnosed as suffering from abnormal carbohydrate
tolerance during pregnancy eight years previously with
those recorded as having normal glucose tolerance. The
prevalence of present abnormal glucose tolerance was
significantly higher in women who had been noted to have
carbohydrate intolerance during their pregnancy, the
prevalence depending on the gestational severity (10.0%
in normal glucose tolerance, 36.4% in borderline GIGT;
66.7% in GIGT). Women whose overweight or obese
status persists or develops after their pregnancy were
statistically more likely to develop abnormal glucose
tolerance later on in life (11.9-12.5% in normal-overweight
BMI, 38.2% in obese BMI). A maternal and sibling, but not
paternal, family history of diabetes was also a statistically
significant risk factor. GIGT appears to be a definite risk
factor for the development of carbohydrate metabolism
problems later on in life, this being related to the severity
during pregnancy and the presence or development of
obesity. It is proposed that women diagnosed to suffer
from GIGT should be regularly monitored after the
pregnancy, particularly if other risk factors such as obesity
are also present.
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INTRODUCTION
It is generally accepted that the pregnancy-state with its
diabetogenic character serves to bring to the forefront
any latent tendency towards the development of
diabetes later on in life. Several follow-up studies in
various populations have concluded that gestational
diabetes mellitus as defined by the 1985 WHO criteria is
conclusively associated with significantly increased risk
of development of DM later on in life, the risk being
highest in women with an elevated fasting blood glucose
(Kerenyi and Tamas, 1994).  The long-term significance
of minor degrees of gestational carbohydrate intolerance
has not yet been definitely elucidated, though a number
of studies have suggested that mild forms of
carbohydrate intolerance during pregnancy may also be
indicators of later risk (O'Sullivan, 1991).
The Maltese population in the Central Mediterranean
has been repeatedly shown to have a high prevalence of
carbohydrate metabolism problems, which is reflected in
the pregnant population (Katona et al., 1983). The
present study was set up to investigate the carbohydrate
metabolism status and anthropomorphic characteristics
of Maltese women who had been diagnosed eight years
previously to suffer from GIGT.
2MATERIAL AND METHODS
Two hundred and sixty-nine women (269) were
metabolically assessed during pregnancy in a
randomised study during Jan-Oct 1985. An attempt was
made to trace and recall this population for re-
assessment eight years later during Jan-Jun 1993. Of
the 116 women [43.1% of the original population] who
responded, there appeared to be a bias towards those
women who had some form of abnormality during
pregnancy. The diagnostic classification for gestational
abnormal glucose tolerance used during the index
pregnancy was based on the 1985 WHO diagnostic
criteria that included women with a blood glucose of 7.8-
11.0 mmol/l 2-hour post 75g glucose load. To conform to
the current diagnostic criteria, the study population
during pregnancy was subdivided into three groups:
normal glucose tolerance [NGT: 2-hour value <7.8
mmol/l], borderline tolerance [borderline GIGT: 2-hour
value 7.8-8.5 mmol/l], and impaired tolerance [GIGT: 2-
hour value 8.6-11.0 mmol/l]. The mean age of these
women was 28.7 + 5.32 years. None of the women in
the study had required insulin treatment during their
pregnancy. The non-pregnant diagnostic criteria for the
75 g oGTT used identified impaired glucose tolerance
and diabetes mellitus with a 2-hour glucose value of 7.8-
11.0 and >11.0 mmol/l respectively, with any 2-hour
post-glucose load value >7.8 mmmol/l being considered
abnormal glucose tolerance.
The anthropomorphic characteristics of the women were
assessed using BMI and waist-hip ratios. Statistical
analysis were made using the chi square test comparing
women found to have carbohydrate intolerance during
the non-pregnant state with those having a normal
glucose tolerance at follow-up using a standard
statistical package MedCalc (1993-97).
RESULTS
The prevalence of abnormal glucose tolerance was
significantly higher in women who had been noted to
have carbohydrate intolerance during their pregnancy,
the prevalence depending on the gestational severity.
Thus women whose gestational metabolic status had
been established as normal had a present abnormal
glucose tolerance prevalence of 10.0 %. In contrast
those women whose gestational status had been
established as borderline GIGT or GIGT now had a
prevalence of 36.4% and 66.7% respectively (Table 1).
The differences were statistically significant for both the
borderline (p=0.0477) and the GIGT group (p<0.0001)
suggesting a strong correlation between gestational
status and subsequent risk of developing carbohydrate
intolerance. Furthermore the severity of the present
carbohydrate intolerance appeared to also be dependent
on the gestational status.  A present diagnosis of
diabetes mellitus was made in 5.6% of women with a
previously normal carbohydrate tolerance during
pregnancy. There were no present cases of diabetes in
women with borderline GIGT. In contrast a diagnosis of
diabetes was made in 53.3% of women with a previous
history of GIGT.
Pregnancy status Present Metabolic Status
Normal IGT DM %
abnormal
glucose
tolerance
Normal glucose tolerance
2-hour value <7.8 mmol/l
81 4 5 10.0
Borderline GIGT
2-hour value 7.8-8.5
7 4 0 36.4
GIGT
2-hour value 8.6-11.0
5 2 8 66.7
Table 1: Previous gestational metabolic status [p<0.0001]
Obesity during pregnancy as determined by BMI did not
appear to have any statistical risk for the development of
subsequent glucose intolerance (Table 2). Thus the
prevalence of follow-up abnormal glucose tolerance was
estimated as 17.0% in women whose gestational BMI
was within the normal range and 22.2% in women
whose gestational BMI was in the overweight-obese
range (p=0.6415). In the follow-up period, obesity as
determined by both a high BMI (p=0.0344) and an
elevated waist-hip ratio (p=0.0364) was however
statistically correlated to a present abnormal glucose
tolerance (Table 3). Hypertension was also statistically
(p=0.0188) associated with an increased prevalence of
abnormal glucose tolerance (Table 3). Family history
was similarly associated with an increased risk of
developing abnormal glucose tolerance (Table 4), this
being statistically significant with a maternal (p=0.0018)
or sibling (p=0.041) family history. A paternal family
history showed no increased risks (p=0.7967).
Pregnancy status Present Metabolic Status
Body stature &
Glucose tolerance
Normal
Tolerance
Abnormal
tolerance
%
abnormal
glucose
tolerance
Normal BMI
Normal glucose tolerance
2-hour value <7.8 mmol/l
Abnormal tolerance
2-hour value >7.8 mmmol/l
44
38
6
9
4
5
17.0
9.5
45.5
Overweight-Obese BMI
Normal glucose tolerance
2-hour value <7.8 mmol/l
Abnormal tolerance
2-hour value >7.8 mmmol/l
49
43
6
14
5
9
22.2
10.4
60.0
Table 2: Pregnancy Body stature and metabolic status
[p=0.6415]
3Present Characteristics Present Metabolic Status
BMI
Normal
Tolerance
2hr value <7.8 mmol/l
Abnormal
Tolerance
2hr value >7.8 mmol/l
% abnormal
glucose
tolerance
Significance
♦ Normal: <25 35 5 12.5
♦ Overweight: 25-29 37 5 11.9
♦ Obese: >30 21 13 38.2 p=0.0344
Waist-Hip ratio
♦ 0.69-0.81 51 7 10.5
♦ 0.82-0.85 24 6 20.0
♦ 0.86-0.94 16 10 38.5 p=0.0364
Blood Pressure
♦ Normotensive 87 17 16.4
♦ Hypertensive >160/90 6 6 50.0 p=0.0188
Table 3: Present Risk factors
Family History Present Metabolic Status
Normal
Tolerance
2hr value <7.8 mmol/l
Abnormal
Tolerance
2hr value >7.8 mmol/l
% abnormal glucose
tolerance
significance
♦ Maternal 22 14 38.9 p=0.0018
♦ Paternal 20 5 20.0 p=0.7967
♦ Sibling 3 4 57.1 p=0.041
Table 4: Family history
DISCUSSION
A number of long-term follow-up studies in different
populations have shown that women who exhibited
carbohydrate intolerance during pregnancy had a
greater likelihood of developing impairment of
carbohydrate metabolism later on in life particularly if
associated with obesity. Integration and comparison of
these studies is fraught by diversity in population
selection, diagnosis criteria and study designs. Women
with gestational abnormal glucose tolerance followed up
in Leningrad 0.25-6 years after delivery were found to
have a 44.2% prevalence of subsequent abnormal
glucose tolerance in contrast to a prevalence of 5.3% in
the control group (O'Sullivan, 1991). Similar findings
were reported in a Danish population where women with
dietary-treated gestational diabetes followed up 2-11
years postpartum had a subsequent abnormal glucose
tolerance prevalence of 24.4% in contrast to 5.3% in
controls. This observation was confirmed in subsequent
studies on the same population that further showed non-
obese glucose tolerant women with previous GDM to be
characterised by the metabolic profile of NIDDM i.e.
insulin resistance and impaired insulin secretion.
(Damm et al., 1992; Damm, 1999). Similarly Swedish
women with previous gestational diabetes followed up 3-
4 years postpartum had a prevalence of abnormal
glucose tolerance of 25.4% in contrast to 4.0% of
controls (Persson et al., 1991). An increased
predisposition towards developing NIDDM in women
with a history of gestational DM was also demonstrated
in Aboriginal women of the Sioux Lookout Zone
(Mohamed and Dooley, 1998).  The present study
confirmed that mild forms of carbohydrate intolerance
during pregnancy appear to be definite risk factors for
the development of carbohydrate metabolism problems
later on in life, this being related to the severity during
pregnancy and the presence or development of obesity.
Pregnancy may thus be considered to be the "crystal
ball" for looking into the future to assess the likelihood of
developing impairment of carbohydrate metabolism later
on in life.
In support of previous epidemiological studies carried
out in the Maltese population (Katona et al., 1983;
Schranz 1989), a maternal or sibling family history has
been found to be a significant risk factor. No such
statistically significant correlation has been identified
with a paternal family history in any of the
epidemiological studies performed in this population.
The maternal, but not paternal, association suggests
that whereas a familiar tendency definitely exists, this is
probably not a purely genetic influence. The familiar
association is more likely the product of the minor
alterations that occur in the intrauterine millieur interieur
of the infant of the mother with abnormal carbohydrate
metabolism. The role of the altered intrauterine
environment in the aetiology of NIDDM has been
previously suggested by epidemiological studies in other
populations. Most convincing are the studies on Pima
Indians which have shown that, besides a genetic
transmission, the diabetic intrauterine environment can
also induce a diabetogenic tendency in the offspring
(Pettit et al., 1988). The relationship has also been
shown by experimental animal models (Aerts and Van
Assche, 1979) and also in human studies (Savona-
Ventura and Schranz, in press).
Since impaired glucose tolerance during pregnancy has
been definitely identified as a significant risk factor
towards development of later NIDDM, particularly in the
presence or development of obesity, it is proposed that
women diagnosed to suffer from GIGT and GDM should
be regularly monitored after the pregnancy to identify the
development of this insidious disorder and its long-term
4complications. Furthermore these women should be
suitably counselled and advised to control their body
weight and reduce their risk of developing NIDDM. The
use of dietary and pharmacological intervention in
women identified as high risk for developing NIDDM
because they had been identified as suffering from
diabetes during their pregnancy has been demonstrated
(Wein et al., 1999).
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